Although pancreatic beta cells produce adequate insulin in infancy, the capacity for insulin production declines thereafter. Diabetes (persistent hyperglycemia) typically develops by early adult years, but may not appear until later decades. The degree of insulin deficiency is slowly progressive. Many patients with MODY 1 are treated with sulfonylureas for years before insulin is required.
^Stokes, A; and Duda K. Comparison of Fatty Acid Ligands in Human HNF4-α Activity and its Role in Diabetes [Abstract]. Ga. J. Sci. 2005, 63(1), 57.
^Duda K, Chi YI, Shoelson SE (2004). "Structural basis for HNF-4alpha activation by ligand and coactivator binding". J. Biol. Chem.279 (22): 23311–6. doi:10.1074/jbc.M400864200. PMID14982928.
^Dhe-Paganon S, Duda K, Iwamoto M, Chi YI, Shoelson SE (2002). "Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand". J. Biol. Chem.277 (41): 37973–6. doi:10.1074/jbc.C200420200. PMID12193589.